Experimental peptides are all the rage on longevity and “optimization” podcasts, but a lot of the chatter is misleading.
KFF Health News gives readers a chance to comment on a recent batch of stories.
The Trump administration has provided few details about its process for canceling hundreds of thousands of Affordable Care Act marketplace enrollments — even as the next stage of the anti-fraud effort is underway.
As early voting begins in some states, the Trump administration is working to keep its crackdown on healthcare fraud, waste, and abuse in the headlines. Also, Health and Human Services Secretary Robert F. Kennedy Jr. has unveiled a new initiative to identify vaccine injuries. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health, Sandhya Raman of Bloomberg Law, and Paige Winfield Cunningham of The Washington Sun join KFF Health News’ Mary Agnes Carey to discuss these stories and more. Also, KFF Health News’ Julie Rovner interviews Dan Weissmann, host of the podcast “An Arm and a Leg.”
Hospitals can prevent medical debt by preemptively wiping out a patient’s bill. But a Tradeoffs analysis finds that few nonprofit facilities in Texas use this tool to the maximum benefit of patients.
Hospitals can prevent medical debt by offering financial help before sending big bills. A Tradeoffs investigation found that nearly half of nonprofit facilities in Texas say they will bill patients before screening them for aid. And most will not offer refunds to patients who pay and are later found to qualify for free care.
These service providers, formerly known as geriatric care managers, can arrange a move to a senior living facility, deal with Medicare and Medicaid, recommend doctors, drive a client to the dentist, and much more.
An initiative on the California ballot would levy the nation’s first wealth tax on billionaires. Supporters say the proceeds would help offset President Donald Trump’s sweeping healthcare cuts. But critics argue that the temporary infusion of cash is a giveaway to politicians.
People who have taken experimental peptides, such as BPC-157, complain of migraines, eye pain, fatigue, and more. Learning whether these popular but unproven drugs are to blame may become harder if Robert F. Kennedy Jr. fulfills a promise to make them more accessible.
A doctor has recommended a course of action that is invasive, expensive, or somehow different from what you'd prefer. Is it OK to get a second opinion? The answer is yes. Here’s how to make the ask a little less awkward.
